US Bancorp DE Sells 1,132 Shares of Exponent, Inc. (NASDAQ:EXPO)

US Bancorp DE cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 7.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,305 shares of the business services provider’s stock after selling 1,132 shares during the quarter. US Bancorp DE’s holdings in Exponent were worth $1,535,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in EXPO. Comerica Bank raised its position in shares of Exponent by 8.7% during the 1st quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock valued at $19,112,000 after buying an additional 18,429 shares in the last quarter. Silvercrest Asset Management Group LLC raised its stake in shares of Exponent by 6.8% during the first quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock valued at $22,864,000 after acquiring an additional 17,496 shares during the last quarter. SG Americas Securities LLC boosted its holdings in shares of Exponent by 601.1% during the first quarter. SG Americas Securities LLC now owns 12,866 shares of the business services provider’s stock worth $1,064,000 after purchasing an additional 11,031 shares during the period. Raymond James & Associates grew its stake in shares of Exponent by 4.1% in the second quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock worth $46,327,000 after purchasing an additional 19,051 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after purchasing an additional 291,047 shares during the period. Institutional investors own 92.37% of the company’s stock.

Analyst Ratings Changes

Separately, Truist Financial reissued a “buy” rating and set a $120.00 target price (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Price Performance

EXPO stock opened at $104.20 on Friday. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75. The firm has a 50-day moving average of $107.71 and a 200 day moving average of $101.25. The company has a market cap of $5.29 billion, a P/E ratio of 50.34 and a beta of 0.69.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Friday, December 6th. Exponent’s payout ratio is presently 54.11%.

Insider Activity at Exponent

In other news, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the sale, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the business’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now directly owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Paul R. Johnston sold 14,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now owns 80,742 shares of the company’s stock, valued at $8,445,613.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by corporate insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.